Comment to FDA on Modified Risk Tobacco Product Application

Commentary

Comment to FDA on Modified Risk Tobacco Product Application

The MRTP pathway is critically important toward reducing the toll of smoking on the U.S. population.

By and

Re: Docket No. FDA-2017-D-3001

Modified Risk Tobacco Product (MRTP) for IQOS System, 82 Fed. Reg. 27487

Guy Bentley is director of consumer freedom at Reason Foundation, a nonprofit think tank advancing free minds and free markets.

Media Contact